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A B S T R A C T
Metastases to the breast from extrammamary neoplasms are very rare. Correct diagnosis of breast malignancy is im-
portant for establishing appropriate management and for avoiding unnecessary radical surgery. Metastasized breast
malignancies from non-small cell lung carcinoma are extremely rare. Here we report a 55-year old female patient with
breast metastasis from lung adenocarcinoma which was diagnosed with fine needle aspiration cytology and confirmed
by immunocytochemistry.
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Introduction
Breast cancer is the commonest malignancy in women
and accounts for 18% of all female cancers1. Metastases
to the breast are unusual and make up approximately 2%
of all malignant mammary neoplasms2. Metastases to the
male breast are encountered even less frequently3. The
commonest cause is spread from a contralateral breast
carcinoma. Patients with unilateral breast carcinoma
have 5-15% risk of developing cancer in the contralateral
breast which may be either synchronous or metachro-
nous. The majority of lesions are second primary growths
rather than metastases1.
Reported primary tumors metastasing to the breast
include melanoma4, hematopoietic malignancies5 and
carcinoma from the lung, genitourinary or gastrointesti-
nal tract5-10. A clinical and radiological presentation of
metastases may mimic both benign and malignant pri-
mary neoplasms. Fine-needle aspiration cytology (FNAC)
or open biopsy of the breast masses is generally per-
formed for diagnosis11-13 The importance of FNAC diag-
nosis is especially stressed, as this can make it possible to
differentiate between a metastasis and a second primary
tumor and thus to avoid unnecessary mastectomy and
ensure that appropriate chemotherapy and radiotherapy
are implemented1. In most cases FNAC permits the cor-
rect diagnosis of a metastatic neoplasm but it is neces-
sary to know the patient’s clinical history and to perform
immunocytochemistry stains on the smears, to arrive at
a definitive diagnosis.
Case Report
A 55-year old female, smoker (50 pack/years) suffered
of a strong pain in her right shoulder and arm and lost 10
kg of weight for four months. Patient came with chest
roentgenogram, CT and bronchoscopy findings done in
another hospital. Chest radiograph followed by a com-
puterized tomographic scan of the chest identified two
suspected nodules in the left upper pulmonary lobe: first
in the core of the lobe, beside pulmonary artery which in-
filtrate the mediastinum (in aorticopulmonary window)
and second in the apex, on the border of anterior and
apicoposterior segment of the lobe, 18 mm in its largest
diameter. CT revealed also enlarged mediastinal and
pretracheal lymph nodes and two well marginated lumps
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in the upper lateral quadrant of her left breast of 27 and
15 mm in its largest diameter which were not identified
on five months old mammographic findings. Broncho-
scopic examination was done but endobronchial cytology
revealed no evidence of malignancy. Patient came to our
hospital for further examination.
She had a firm mobile palpable lesion in the upper
outer quadrant of her left breast, about 30 mm in its
largest diameter which patient notice two weeks ago like
small mass with very rapid growth. Bronchoscopy was
repeated and proved subsegmental orifice mucosa of an-
terior bronchi of the upper left pulmonary lobe, infil-
trated with tumor. Bronchial washings and brushings
specimens obtained by bronchoscopy revealed medium to
large malignant cells isolated and in loosely cohesive
groups, variable in size with dense, abundant and vacuo-
lated cytoplasm and round to oval, usually eccentric nu-
clei, with finely granular chromatin and nucleoli. The cy-
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Fig. 1. and Fig. 2. Two breast masses with 27 and 15 mm in diameter in the upper outer quadrant of the left breast noted on mammogra-
phy examination (in mediolateral and craniokaudal projection).
Fig. 3. and Fig. 4. The same two breast masses on CT examination.
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tological diagnosis was adenocarcinoma. Repeated mam-
mography examination of her left breast showed two
nodules in the upper outer quadrant of 20 and 30 mm in
its largest diameter. Ultrasound examination was per-
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Fig. 5. One pappilary group of adenocarcinoma cells, in bron-
chial washing specimen, variable in size with abundant and vacu-
olated cytoplasm and round to oval, usually eccentric nuclei, finely
granular chromatin and prominent nucleoli. Some carcinoma cells
containing neutrophils in their cytoplasm – emperipolesys phe-
nomen. (May-Grünwald-Giemsa stain, x200).
Fig. 6. Adenocarcinoma cells, in bronchial brushing specimen,
isolated and in loosely cohesive groups, one carcinoma cell is in
mytosis. Erythrocytes and some small lymhocytes and neutro-
phils in the background (May-Grünwald-Giemsa stain, x200).
Fig. 8. Adenocarcinoma cells in FNAC specimen positive for cyto-
keratin 7 (Immunocytochemistry, x100).
Fig. 7. Adenocarcinoma cells in FNAC specimens of the left breast
show the same cytomorphology as in bronchial washing and brush-
ing specimens (May-Grünwald-Giemsa stain, x200).
Fig. 9. Adenocarcinoma cells in FNAC specimen negative for cyto-
keratin 20 (Immunocytochemistry, x200).
Fig. 10. Adenocarcinoma cells in FNAC specimen positive for thy-
roid transcription factor 1 (Immunocytochemistry, x200).
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formed with fine needle aspiration cytology of the big-
gest, 30 mm lesion of her left breast. FNAC was per-
formed using 22-gauge needle. Slides were air-dried and
stained using the May-Grünwald-Giemsa method. An
FNAC procedure yielded abundant material consisting of
a population of slightly cohesive groups as well as iso-
lated malignant cells with abundant and vacuolated cyto-
plasm, round to oval eccentric nuclei and nucleoli. Ade-
nocarcinoma was diagnosed. In our case, primary lung
malignancy was known, so metastatic lesion was consid-
ered in the differential diagnosis of tumor of the breast.
The cytological slides of the primary lung tumor were re-
viewed and compared with the fine needle aspiration cy-
tological slides of the left breast. Immunocytochemistry
was performed on the smear to corroborate the diagnosis
and showed malignant cells positive for cytokeratin 7
and thyroid transcription factor 1 (TTF-1) and negative
for cytokeratin 20. Metastatic lung adenocarcinoma was
diagnosed. Patient started with therapy treatment in an-
other hospital.
Discussion
Metastasis to the breast from extrammamary carcino-
mas is extremely rare14,15. In previously reported clinical
series ranges from 0.5-2% of all breast malignancies16-18
and in autopsy series, the range of the incidence is from
1,7-6,6%18,19. Metastatic lesions are not distinguishable
from primary tumors clinically, radiologically and some-
times even cytopathologically. Besides leukemia or lym-
phoma, breast metastases have been reported to be most
commonly from melanoma, rhabdomyosarcoma and the
lung20. Metastases from solid organs, such as the lung,
skin, kidney and stomach were more frequently in the
earlier part of the last century and in the latter part of
the last century involvement of the breast by hematolo-
gic malignancies is becoming relatively more common3.
Clinically, metastatic lesions are not distinguishable
from primary tumors. Presentation with pain, tender-
ness and discharge is distinctly unusual11,21. A solitary le-
sion is the most common clinical presentation, while
well-defined nodules have been seen in 11% of cases and
diffuse involvement in 4%22. 26% of cases had bilateral
lesions. The lesion tends to be superficially located in the
upper outer quadrant. 25% of cases had adherence to the
skin and nipple retraction never has been reported. Axil-
lary lymph node involvement is frequently encountered1.
Metastatic lesions may grow rapidly but the majority of
cases present with a firm freely mobile lump mimicking
benign disease. Rarely a large rapidly growing lesion may
be confused with inflammatory breast carcinoma14.
Radiology may be more successful in differentiating
the metastatic from primary tumor. Radiographic dis-
tinction is extremely difficult because of the wide spec-
trum of presentation of the metastatic nodules. They
may mimic a primary breast carcinoma or even a benign
abnormality radiographically. This includes presentation
with single or multiple lesions with or without dermal in-
volvement and almost always without microcalcifications
which occurs mainly in patients with metastatic ovarian
carcinoma containing psammoma bodies23,24. Metastases
are more likely to be multiple and frequently bilateral:
perhaps owing to their centripetal growth, they form a
nidus of tumor cells that are usually round with fairly
well-defined margins21,25,26. In our presented case, the
patient has multiple, well-circumscribed metastases. Le-
sions, that metastasize to the breast, presented on ultra-
sound examination like usually round or ovoid, with
some degree of lobulation, with variable internal echoes
ranging from scattered low-amplitude signals to hetero-
geneous fairly prominent reflections. The posterior ech-
oes are usually preserved, and as with all round solid
breast masses, relative enhancement may occur26. Most
types of metastatic tumors in the breast can be accu-
rately diagnosed by needle aspiration cytology or exci-
sional biopsy if the patient has previously diagnosed
non-mammary malignant neoplasms, but clinical corre-
lation with previous specimens, special stains and immu-
nocytochemistry are necessary for an accurate diagno-
sis27
Pathologically, it can be also difficult to recognize tu-
mor as metastatic3. The distinction of primary breast
malignancy from metastases on cytohistology is based on
features not usually seen in primary tumors of breast,
such as intracytoplasmic pigment melanin in melanoma,
small undifferentiated cells in small cell lung carcinoma
and hematopoietic cells. Difficulty arises in tumors with
similar morphologic pattern as primary carcinoma of the
breast28. Particularly in patients with metastatic adeno-
carcinoma diagnosis with recourse to immunocyto/histo-
chemistry is difficult or impossible29. On the other hand,
some primary breast tumors have unexpected morpho-
logic appearances that can be mistaken for tumors usu-
ally encountered outside the breast. Examples of such tu-
mors include primary signet ring carcinoma and pure
squamous cell carcinoma of the breast3. There are some
histologic indicators that may aid in recognition of sec-
ondary tumors. Azzopardi has commented that elastosis
is a consistent indicator of primary neoplasms but is
rarely seen in secondary tumors30. Lee et al. claimed that
carcinoma in situ were seen only in primary mammary
cancers31. Other factors for metastatic rather than pri-
mary origin include a sharp transition at the border of
the lesion and the presence in the subcutaneous, rather
than parenchymal breast tissue. Vergier and al. identi-
fied a number of characteristics typical of metastases,
namely atypical histologic features for a primary breast
carcinoma, a well-circumscribed tumor with multiple
satellite foci, the absence of an intraductal component
and the presence of many lymphatic emboli32.
In our case, after cytomorphological correlation of pri-
mary lung adenocarcinoma and fine-needle aspiration
cytology specimens of the left breast, the possibility of
metastases was considered first. Immunocytochemistry
techniques are undoubtedly proved metastases of pulmo-
nary origin. Adenocarcinoma of both, breast and lung
show the same immunochemical pattern for cytokeratin
7 and 20, so we also used thyroid transcription factor 1
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which nuclear reactivity serve as a marker of pulmonary
origin. It is important to keep in mind that thyroid carci-
noma may express this marker, so metastatic thyroid car-
cinoma to the lung is a potential diagnostic trap. In our
case cytomorphological features eliminated thyroid ori-
gin of carcinoma. The treatment of secondary malig-
nancy of the breast should be directed of the primary dis-
ease. Surgical therapy should be as conservative as
possible and usually entails wide local excision.
In summary, in the evaluation of a patient presenting
with a breast mass metastatic disease of the breast must
be considered in the differential diagnosis. Aspiration cy-
tology plays a major role in differentiating metastases
from a primary breast tumor, but with complete knowl-
edge of the clinical history of the patient. Unusual cytol-
ogy pattern should raise the possibility of metastases and
then immunocytochemistry staining can be very useful.
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METASTAZA PLU]NOG ADENOKARCINOMA U DOJCI DIJAGNOSTICIRANA CITOLO[KOM
PUNKCIJOM: PRIKAZ SLU^AJ
S A @ E T A K
Metastaze u dojku od strane primarnih malignih neoplazmi izvan dojke su vrlo rijetke. To~na dijagnoza maligne
bolesti dojke je va`na, kako za odre|ivanje pravilnog terapijskog tretmana, tako i zbog izbjegavanja nepotrebnog ra-
dikalnog kirur{kog zahvata. Metastaze plu}nih karcinoma ne-malih stanica u dojku su ekstremno rijetke. Prikazujemo
slu~aj 55-godi{nje `ene sa metastazom adenokarcinoma plu}a u dojku {to je dokazano citolo{kom punkcijom i potvr-
|eno imunocitokemijskom obradom.
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